Emerson Electric (EMR) and Ingersoll Rand (IR) are two large-cap industrials that appeal to investors seeking exposure to automation, energy transition, and mission-critical equipment. Although both companies serve industrial end markets, their business models, growth drivers, and recent stock behavior have diverged meaningfully. This stock comparison is relevant for traders and longer-term investors evaluating relative performance, market positioning, and how AI-driven tools might weigh the two names in the current environment. The sections below examine each company's recent performance, key catalysts, and risk factors to clarify where the balance of observable evidence currently sits.
Emerson Electric is a global industrial technology leader focused on advanced automation, combining intelligent devices, control systems, and industrial software. The company operates through two broad areas: Intelligent Devices and Software & Control, the latter including its Test & Measurement and software businesses. In its most recent fiscal results, Emerson reported net sales growth of about 5% year over year, with adjusted earnings per share (EPS) up roughly 9%, driven by strength in its Software & Control segment and continued margin expansion.
Recent market activity has been constructive for the stock. Emerson's underlying orders rose for a third consecutive quarter at a mid-single-digit rate, and management highlighted sustained demand across power, LNG (liquefied natural gas), life sciences, and aerospace and defense verticals. The company also completed the integration of its Test & Measurement acquisition and made progress on AspenTech synergies, while raising its dividend and authorizing additional share repurchases. These catalysts, combined with resilience in maintenance and repair operations (MRO) spending across its installed base, have supported a more favorable sentiment and relative performance in recent weeks.
Ingersoll Rand is a diversified industrial company providing mission-critical flow creation and industrial and life sciences solutions, operating through Industrial Technologies & Services and Precision & Science Technologies segments. In its most recent quarter, the company delivered double-digit year-over-year revenue growth that exceeded consensus expectations, alongside a modest beat on adjusted EPS, helped by recurring revenue expansion and a healthy backlog.
Despite solid headline results, sentiment has been more mixed. Management has flagged tariff-related cost pressures, particularly from Section 232 tariffs on steel and aluminum, and delayed pricing realization as the primary drags on margins. Organic revenue growth has also been more subdued in certain core industrial end markets. Over the past 52 weeks, the stock has underperformed meaningfully, trading below its 200-day moving average and lagging the broader market. Analysts remain broadly constructive with a consensus "Moderate Buy" rating, but near-term momentum and margin visibility have weighed on the shares relative to peers.
Tickeron maintains a large library of AI trading bots that collectively trade thousands of different tickers using distinct strategies, timeframes, and risk profiles. Rather than surfacing all of them at once, Tickeron curates only the most suitable performers for current market conditions into its Trending AI Robots section. This curated list highlights bots with notable recent statistics across metrics such as win rate, return, and trade frequency, helping traders filter for strategies that align with their own approach. Because each bot trades a different set of tickers and operates on its own style and timeframe, the page offers a practical starting point for comparing automated strategies. Traders interested in data-driven market positioning may find it useful to review the Trending AI Robots page directly.
The two companies differ most clearly in business model focus and momentum. Emerson is centered on automation and industrial software, a positioning that carries higher recurring revenue characteristics and secular tailwinds tied to digital transformation, power, and LNG investment. Ingersoll Rand, by contrast, spans a broader set of flow-creation and life-science products, leaning more heavily on acquisition-driven growth and aftermarket service expansion.
Growth drivers also diverge. Emerson's recent strength has come from organic order momentum and software annual contract value growth, while Ingersoll Rand has leaned on disciplined bolt-on M&A (mergers and acquisitions) and recurring revenue expansion to offset softer organic growth. On risk factors, Ingersoll Rand faces more immediate margin headwinds from tariffs and pricing lag, whereas Emerson's exposure is more concentrated in industrial capital spending cycles and softer demand in Europe and China. In terms of relative performance, Emerson has shown more stable, positive momentum, while Ingersoll Rand has remained in a bearish technical posture despite supportive analyst ratings.
Based on observable factors such as trend consistency, stability, catalysts, and relative positioning, Tickeron's AI framework would currently lean toward EMR over IR. Emerson's combination of consecutive quarters of improving order growth, expanding margins, higher-margin software revenue, and a comparatively stronger and more consistent price trend presents a more favorable risk-reward profile in the present market environment. Ingersoll Rand retains constructive long-term characteristics, including a growing recurring revenue base and an active M&A pipeline, but its ongoing tariff-related margin pressure and lagging price momentum weigh on the near-term picture. This assessment is probabilistic rather than definitive and reflects the current balance of available data rather than a guaranteed outcome.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Be on the lookout for a price bounce soon.
EMR moved above its 50-day moving average on November 18, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +2.70% 3-day Advance, the price is estimated to grow further. Considering data from situations where EMR advanced for three days, in 219 of 345 cases, the price rose further within the following month. The odds of a continued upward trend are 63%.
The Aroon Indicator entered an Uptrend today. In 164 of 274 cases where EMR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 60%.
The 10-day RSI Indicator for EMR moved out of overbought territory on October 30, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 42 similar instances where the indicator moved out of overbought territory. In 21 of the 42 cases, the stock moved lower in the following days. This puts the odds of a move lower at 50%.
The Momentum Indicator moved below the 0 level on November 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on EMR as a result. In 57 of 90 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 63%.
The Moving Average Convergence Divergence Histogram (MACD) for EMR turned negative on November 05, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In 22 of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at 50%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where EMR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 56%.
EMR broke above its upper Bollinger Band on October 27, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Profit vs. Risk Rating rating for this company is 18 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 75, placing this stock better than average.
The Tickeron PE Growth Rating for this company is 30 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 44 (best 1 - 100 worst), indicating steady price growth. EMR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 62 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 81 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.444) is normal, around the industry mean (3.843). P/E Ratio (35.370) is within average values for comparable stocks, (36.971). Projected Growth (PEG Ratio) (1.837) is also within normal values, averaging (1.879). Dividend Yield (0.015) settles around the average of (0.032) among similar stocks. P/S Ratio (4.409) is also within normal values, averaging (189.487).
The 10-day moving average for IR crossed bullishly above the 50-day moving average on October 15, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 11 of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 79%.
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
IR moved above its 50-day moving average on October 29, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +6.14% 3-day Advance, the price is estimated to grow further. Considering data from situations where IR advanced for three days, in 212 of 322 cases, the price rose further within the following month. The odds of a continued upward trend are 66%.
The Aroon Indicator entered an Uptrend today. In 187 of 269 cases where IR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 70%.
The 10-day RSI Indicator for IR moved out of overbought territory on November 10, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 39 similar instances where the indicator moved out of overbought territory. In 21 of the 39 cases, the stock moved lower in the following days. This puts the odds of a move lower at 54%.
The Momentum Indicator moved below the 0 level on November 17, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on IR as a result. In 45 of 85 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 53%.
The Moving Average Convergence Divergence Histogram (MACD) for IR turned negative on November 17, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 51 similar instances when the indicator turned negative. In 30 of the 51 cases the stock turned lower in the days that followed. This puts the odds of success at 59%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 60%.
IR broke above its upper Bollinger Band on November 02, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Price Growth Rating for this company is 32 (best 1 - 100 worst), indicating outstanding price growth. IR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 39 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Profit vs. Risk Rating rating for this company is 53 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 75, placing this stock slightly better than average.
The Tickeron Valuation Rating of 67 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.164) is normal, around the industry mean (3.843). P/E Ratio (34.152) is within average values for comparable stocks, (36.971). Projected Growth (PEG Ratio) (0.619) is also within normal values, averaging (1.879). Dividend Yield (0.001) settles around the average of (0.032) among similar stocks. P/S Ratio (3.547) is also within normal values, averaging (189.487).
The Tickeron SMR rating for this company is 73 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 86 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
EMR | IR | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 84 | 83 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 81 Overvalued | 67 Overvalued | |
PROFIT vs RISK RATING 1..100 | 18 | 53 | |
SMR RATING 1..100 | 62 | 73 | |
PRICE GROWTH RATING 1..100 | 44 | 32 | |
P/E GROWTH RATING 1..100 | 30 | 86 | |
SEASONALITY SCORE 1..100 | 50 | 39 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
IR's Valuation (67) in the Industrial Conglomerates industry is in the same range as EMR (81) in the Electrical Products industry. This means that IR’s stock grew similarly to EMR’s over the last 12 months.
EMR's Profit vs Risk Rating (18) in the Electrical Products industry is somewhat better than the same rating for IR (53) in the Industrial Conglomerates industry. This means that EMR’s stock grew somewhat faster than IR’s over the last 12 months.
EMR's SMR Rating (62) in the Electrical Products industry is in the same range as IR (73) in the Industrial Conglomerates industry. This means that EMR’s stock grew similarly to IR’s over the last 12 months.
IR's Price Growth Rating (32) in the Industrial Conglomerates industry is in the same range as EMR (44) in the Electrical Products industry. This means that IR’s stock grew similarly to EMR’s over the last 12 months.
EMR's P/E Growth Rating (30) in the Electrical Products industry is somewhat better than the same rating for IR (86) in the Industrial Conglomerates industry. This means that EMR’s stock grew somewhat faster than IR’s over the last 12 months.
| EMR | IR | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 50% | 2 days ago 54% |
| Stochastic ODDS (%) | 2 days ago 67% | 2 days ago 67% |
| Momentum ODDS (%) | 2 days ago 63% | 2 days ago 53% |
| MACD ODDS (%) | 2 days ago 50% | 2 days ago 59% |
| TrendWeek ODDS (%) | 2 days ago 58% | 2 days ago 61% |
| TrendMonth ODDS (%) | 2 days ago 57% | 2 days ago 65% |
| Advances ODDS (%) | 16 days ago 63% | 11 days ago 66% |
| Declines ODDS (%) | 3 days ago 56% | 3 days ago 60% |
| BollingerBands ODDS (%) | 2 days ago 60% | 2 days ago 56% |
| Aroon ODDS (%) | 2 days ago 60% | 2 days ago 70% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
EMR’s FA Score shows that 2 FA rating(s) are green while IR’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
EMR’s TA Score shows that 4 TA indicator(s) are bullish while IR’s TA Score has 5 bullish TA indicator(s).
EMR (@Industrial Machinery) experienced а -2.68% price change this week, while IR (@Industrial Machinery) price change was -2.89% for the same time period.
The average weekly price growth across all stocks in the @Industrial Machinery industry was -6.67%. For the same industry, the average monthly price growth was -8.45%, and the average quarterly price growth was -21.26%.
EMR is expected to report earnings on Feb 10, 2027.
IR is expected to report earnings on Feb 18, 2027.
The industry makes and maintains machines for consumers, the industry, and most other companies. While it has traditionally been categorized as heavy industry, some smaller companies are also branching into the light category. The industry is pivotal in providing the equipment for production in businesses like agriculture, mining, industry and construction, gas, electricity and water utilities. It also supplies supporting equipment for almost all sectors of the economy, such as equipment for heating, and air conditioning of buildings. Illinois Tool Works Inc., Parker-Hannifin Corporation and Rockwell Automation Inc are some of the major U.S. companies operating in this industry.
A.I.dvisor indicates that over the last year, EMR has been closely correlated with AME. These tickers have moved in lockstep 74% of the time. This A.I.-generated data suggests there is a high statistical probability that if EMR jumps, then AME could also see price increases.
| Ticker / NAME | Correlation To EMR | 1D Price Change % | ||
|---|---|---|---|---|
| EMR | 100% | -2.72% | ||
| AME - EMR | 74% Closely correlated | -1.89% | ||
| IR - EMR | 70% Closely correlated | -2.48% | ||
| ROK - EMR | 70% Closely correlated | -3.22% | ||
| LECO - EMR | 69% Closely correlated | -2.00% | ||
| GTES - EMR | 66% Closely correlated | -4.37% | ||
More | ||||
A.I.dvisor indicates that over the last year, IR has been closely correlated with JCI. These tickers have moved in lockstep 77% of the time. This A.I.-generated data suggests there is a high statistical probability that if IR jumps, then JCI could also see price increases.